Erul Enes, Gülpınar Ömer, Kuru Öz Diğdem, Berber Havva, Kiremitci Saba, Ürün Yüksel
Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara 06620, Türkiye.
Department of Urology, Ankara University Faculty of Medicine, Ankara 06620, Türkiye.
Medicina (Kaunas). 2024 Nov 22;60(12):1918. doi: 10.3390/medicina60121918.
: Primary prostatic stromal sarcoma is an exceptionally rare urological malignancy, constituting less than 0.1% of all prostatic cancers. It poses a significant clinical challenge due to its aggressive behavior and poor prognosis. : We report the case of a 34-year-old male who presented with nonspecific lower urinary tract symptoms, including dysuria and increased urinary frequency. The initial diagnostic workup, including digital rectal examination and Magnetic Resonance Imaging (MRI), revealed a lobulated lesion within the prostate. A transurethral resection (TUR) was performed for diagnostic purposes, and histopathological examination revealed a "malignant mesenchymal tumor". The patient underwent a laparoscopic radical prostatectomy. The pathology report confirmed the diagnosis of prostatic stromal sarcoma. The postoperative follow-up, including systemic CT and MRI, showed no evidence of recurrence or metastasis thus far. : Multidisciplinary management is essential for optimizing treatment outcomes in all urologic malignancies; however, it becomes particularly challenging and crucial in rare cases such as primary prostatic stromal sarcoma. In our case, the patient benefited from a coordinated approach involving urology, pathology, and oncology, underscoring the importance of collaborative care for rare and aggressive tumors like this. This case highlights the importance of early detection, complete surgical excision, and consideration of adjuvant therapies, given the aggressive nature of the disease. The role of novel therapeutic strategies, including immunotherapy and targeted therapies, is also discussed in the context of metastatic sarcomas. : This case underscores the critical need for a comprehensive, multidisciplinary approach to managing primary prostatic stromal sarcoma. Ongoing research on innovative therapies offers hope for improved outcomes in metastatic stages.
原发性前列腺间质肉瘤是一种极为罕见的泌尿系统恶性肿瘤,占所有前列腺癌的比例不到0.1%。由于其侵袭性生物学行为和预后较差,它构成了重大的临床挑战。
我们报告一例34岁男性患者,其表现为非特异性下尿路症状,包括排尿困难和尿频。初始诊断检查,包括直肠指检和磁共振成像(MRI),显示前列腺内有一个分叶状病变。为明确诊断进行了经尿道切除术(TUR),组织病理学检查显示为“恶性间叶肿瘤”。患者接受了腹腔镜根治性前列腺切除术。病理报告证实为前列腺间质肉瘤。术后随访,包括全身CT和MRI,目前未发现复发或转移迹象。
多学科管理对于优化所有泌尿系统恶性肿瘤的治疗效果至关重要;然而,在原发性前列腺间质肉瘤等罕见病例中,这变得尤其具有挑战性且至关重要。在我们的病例中,患者受益于泌尿外科、病理学和肿瘤学的协同治疗方法,突显了针对此类罕见且侵袭性肿瘤进行协作护理的重要性。鉴于该疾病的侵袭性,本病例强调了早期检测、完整手术切除以及考虑辅助治疗的重要性。在转移性肉瘤的背景下,还讨论了包括免疫治疗和靶向治疗在内的新型治疗策略的作用。
本病例强调了采用全面、多学科方法管理原发性前列腺间质肉瘤的迫切需求。正在进行的关于创新疗法的研究为改善转移性阶段的治疗结果带来了希望。